Embry Holdings Limited (HK:1388)
:1388
Want to see HK:1388 full AI Analyst Report?
Top Page
Embry Holdings Limited
(1388)
Select Model
Select Model
Rating:44Neutral
Price Target:
HK$0.32
▼(-20.00% Downside)
Action:ReiteratedDate:04/29/26
The score is primarily weighed down by weak financial performance: sustained losses and a shift to negative operating/free cash flow despite strong gross margins and only moderate leverage. Technicals add pressure, with the stock trading below all major moving averages and bearish momentum indicators. Valuation provides limited support because the negative P/E reflects unprofitability and no dividend yield data is available.
Positive Factors
Very high gross margins
Sustained 70–75% gross margins indicate strong unit economics from product mix, pricing and manufacturing control. That margin buffer supports long-term profitability potential if operating costs are reined in, and gives time to execute restructuring or growth investments.
Negative Factors
Persistent operating and net losses
Chronic operating losses and a ~-22% net margin show the company fails to convert strong gross margins into profitable operations. Over months, continued losses erode reserves, weaken competitive positioning and make it harder to invest in growth or cost transformation without external capital.
Read all positive and negative factors
Positive Factors
Negative Factors
Very high gross margins
Sustained 70–75% gross margins indicate strong unit economics from product mix, pricing and manufacturing control. That margin buffer supports long-term profitability potential if operating costs are reined in, and gives time to execute restructuring or growth investments.
Read all positive factors
Embry Holdings Limited (1388) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$145.73M
Dividend YieldN/A
Average Volume (3M)28.67K
Price to Earnings (P/E)―
Beta (1Y)0.41
Revenue Growth1.51%
EPS Growth32.19%
CountryHK
Employees3,949
SectorConsumer Cyclical
Sector Strength84
IndustryApparel - Manufacturers
Share Statistics
EPS (TTM)-0.46
Shares Outstanding422,416,630
10 Day Avg. Volume7,200
30 Day Avg. Volume28,666
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.10
Price to Sales (P/S)0.13
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Embry Holdings Limited Business Overview & Revenue Model
Company Description
Embry Holdings Limited, an investment holding company, designs, researches, develops, manufactures, trades in, and sells ladies brassieres, panties, swimwear, and sleepwear. The company sells its lingerie products primarily under the EMBRY FORM, F...
How the Company Makes Money
null...
Embry Holdings Limited Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
58
Neutral
Cash Flow
32
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.17B | 1.15B | 1.28B | 1.33B | 1.65B |
| Gross Profit | 818.45M | 848.67M | 956.10M | 1.00B | 1.21B |
| EBITDA | -88.40M | -268.27M | 15.40M | 65.16M | 131.00M |
| Net Income | -253.18M | -373.44M | -72.17M | -51.24M | -27.48M |
Balance Sheet | |||||
| Total Assets | 2.32B | 2.37B | 2.86B | 2.98B | 3.30B |
| Cash, Cash Equivalents and Short-Term Investments | 189.79M | 163.43M | 283.61M | 380.18M | 378.64M |
| Total Debt | 476.52M | 363.43M | 342.33M | 384.05M | 425.35M |
| Total Liabilities | 775.23M | 642.66M | 704.09M | 704.47M | 788.50M |
| Stockholders Equity | 1.55B | 1.72B | 2.16B | 2.27B | 2.52B |
Cash Flow | |||||
| Free Cash Flow | -37.17M | -90.39M | 9.81M | 116.54M | 154.28M |
| Operating Cash Flow | -26.61M | -81.62M | 37.95M | 137.71M | 166.04M |
| Investing Cash Flow | -17.95M | -8.73M | -17.00M | -27.45M | -11.54M |
| Financing Cash Flow | 41.05M | -3.11M | -101.46M | -74.50M | -215.72M |
Embry Holdings Limited Technical Analysis
Negative
0.40
Price Trends
0.39
Negative
0.38
Negative
0.40
Negative
Market Momentum
>-0.01
Positive
43.30
Neutral
26.19
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1388, the sentiment is Negative. The current price of 0.4 is above the 20-day moving average (MA) of 0.37, above the 50-day MA of 0.39, and below the 200-day MA of 0.40, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 43.30 is Neutral, neither overbought nor oversold. The STOCH value of 26.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1388.
Embry Holdings Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$850.00M | 4.72 | 19.30% | 8.89% | 2.88% | -2.13% | |
67 Neutral | HK$2.40B | 4.54 | 8.52% | 4.00% | 3.40% | 151.24% | |
63 Neutral | HK$1.75B | 2.63 | 12.81% | 7.98% | 13.52% | 4.95% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | HK$1.06B | 5.21 | 5.79% | 6.04% | -1.81% | -2.23% | |
46 Neutral | HK$823.83M | -11.23 | -17.17% | ― | -13.06% | -197.89% | |
44 Neutral | HK$145.73M | -0.62 | -20.24% | ― | 1.51% | 32.19% |
* Consumer Cyclical Sector Average
HK:1388
Embry Holdings Limited
0.33
-0.07
-17.50%
HK:1425
Justin Allen Holdings Limited
0.70
0.04
6.06%
HK:1906
Bonny International Holding Ltd.
0.56
0.20
55.56%
HK:2199
Regina Miracle International (Holdings) Limited
1.86
0.32
20.94%
HK:2298
Cosmo Lady (China) Holdings Co. Ltd.
0.47
0.24
106.14%
HK:2368
Eagle Nice (International) Holdings Ltd.
3.00
-0.14
-4.46%
Embry Holdings Limited Corporate Events
Embry Holdings sets 2026 AGM to renew share issue and buy-back mandates
Apr 23, 2026
Embry Holdings Limited has convened its annual general meeting for 28 May 2026 in Hong Kong, where shareholders will review the audited financial statements for the year ended 31 December 2025 and receive reports from the board and the external au...
Embry Holdings Narrows Annual Loss Despite Flat Revenue and Ongoing Impairments
Mar 27, 2026
Embry Holdings Limited reported revenue of HK$1,169.98 million for the year ended 31 December 2025, a slight increase from HK$1,152.57 million in 2024, but the group remained loss-making with a net loss attributable to owners of HK$253.18 million....
Embry Holdings flags narrower 2025 loss on reduced impairments and FX gain
Mar 13, 2026
Embry Holdings Limited has warned that it expects to post a reduced loss attributable to shareholders of about HK$250 million to HK$260 million for the year ended 31 December 2025, narrowing from a loss of roughly HK$373 million a year earlier. Th...
Embry Holdings Sets March Board Meeting to Approve 2025 Final Results
Mar 10, 2026
Embry Holdings Limited has scheduled a board meeting for 27 March 2026 to review and approve the audited final results for the financial year ended 31 December 2025. The board will also consider whether to recommend a final dividend, a decision th...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.